Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma

Liu, Y; Deng, BP; Hu, B; Zhang, WQ; Zhu, Q; Liu, Y; Wang, S; Zhang, P; Yang, Y; Yang, JH; Zheng, QL; Yu, XJ; Gao, ZF; Zhou, CJ; Han, W; Yang, J; Jin, L; Tong, CR; Chang, AH; Zhang, YH

Zhang, YH (通讯作者),Beijing Boren Hosp, Dept Pediat Lymphoma, 6 South Zhengwangfen, Beijing 100070, Peoples R China.;Chang, AH (通讯作者),Tongji Univ, Shanghai Pulm Hosp, Clin Translat Res Ctr, Sch Med, Shanghai 200438, Peoples R China.

BLOOD ADVANCES, 2022; 6 (3): 717

Abstract

Single antigen-targeted chimeric antigen receptor (CAR) T-cell therapy maybe insufficient to induce a durable response in pediatric aggressive B-cell ......

Full Text Link